NewAmsterdam Pharma Company NAMS Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by NewAmsterdam Pharma Company in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The official record: NewAmsterdam Pharma Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about NewAmsterdam Pharma Company's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is NewAmsterdam Pharma Company's common stock?
- NewAmsterdam Pharma Company (NAMS) reported common stock of $14.59M in Q1 2026.
- How has NewAmsterdam Pharma Company's common stock changed year-over-year?
- NewAmsterdam Pharma Company's common stock increased by 4.5% year-over-year, from $13.97M to $14.59M.
- What is the long-term trend for NewAmsterdam Pharma Company's common stock?
- Over 3 years (2022 to 2025), NewAmsterdam Pharma Company's common stock has grown at a 12.4% compound annual growth rate (CAGR), from $10.06M to $14.28M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).